3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Motor Activity
12
Breast Neoplasms
9
Fatigue
8
Neoplasms
7
Cognitive Dysfunction
3
Colorectal Neoplasms
2
Stomach Neoplasms
1
Rectal Neoplasms
1
Postoperative Bowel Functions
1
Polycystic Ovary Syndrome
1
Parasomnias
1
Obesity
1
Metabolic Syndrome
1
Lymphoma, Follicular
1
Lung Neoplasms
1
Liver Neoplasms
1
Esophageal Neoplasms
1
Colonic Neoplasms
1
Carcinoma, Non-Small-Cell Lung
1
Biliary Tract Neoplasms
1
Asthenia
1
Arthralgia
1
Adenomatous Polyps
1
Interventions
Metformin
149
Clomiphene
51
Letrozole
39
Inositol
35
Folic Acid
18
Exercise
17
Progesterone
15
Ethinyl Estradiol
13
Chorionic Gonadotropin
13
Caloric Restriction
13
drospirenone and ethinyl estradiol combination
12
Estradiol
12
Contraceptives, Oral
11
cetrorelix
10
Pioglitazone
10
High-Intensity Interval Training
10
Tablets
9
Spironolactone
9
Cholecalciferol
9
Triptorelin Pamoate
8
Diet
8
Vitamin D
7
Thioctic Acid
7
Menotropins
7
Liraglutide
7
Acupuncture Therapy
7
drospirenone
6
Ovidrel
6
Gonadotropins
6
Flutamide
6
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Polycystic Ovary Syndrome
×
Walking
×
Clear all
NCT07157371
2025-09-05
SSAET
Riphah International University
Phase NA
Active not recruiting
60 enrolled